Haploidentical hematopoietic stem cell transplantation with myeloablative conditioning regimen could serve as an optional salvage therapy for younger patients with refractory or relapsed aggressive non-Hodgkin lymphoma. Article uri icon

Overview

publication date

  • May 16, 2017

Research

keywords

  • Hematopoietic Stem Cell Transplantation
  • Lymphoma, Non-Hodgkin
  • Transplantation Conditioning

Identity

Scopus Document Identifier

  • 85019194486

Digital Object Identifier (DOI)

  • 10.1080/10428194.2017.1317096

PubMed ID

  • 28509575

Additional Document Info

volume

  • 58

issue

  • 12